Posts in category: Uncategorized

A new study in mice shows that consuming emulsifiers—a common ingredient in ultra-processed human foods—during pregnancy or breast-feeding is associated with mild health risks for offspring. Maria Milà-Guasch of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona, Spain, and colleagues present these findings August 24 in the open access journal PLOS Biology.

Researchers report that age-related hearing loss is associated with a decrease of cholesterol in the inner ear.

Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys.

A study led by Dr. Hyun Kyoung Lee, associate professor at Baylor College of Medicine and investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, has discovered a new biological mechanism to regenerate and repair myelin, a protective sheath that insulates neuronal fibers and plays a vital role in ensuring rapid and accurate neurotransmission.

THE Zambia Police Service says the planned rally which the opposition Patriotic Front(PF) is scheduled to hold this Saturday will not take place owing to “security concerns”. Instead, the police has advised the largest opposition party to hold the public procession on an alternative period towards the end of September 2023. Police spokesperson Rase Hamoonga […]

A pioneering drug for a rare kidney disease prevents organ failure and significantly improves the outcome for patients, new research has confirmed.

By NATION REPORTER

THE Centre for Environment Justice (CEJ) has launched a project dubbed “Strengthening Civil Society Voices for Climate Advocacy in Zambia”.

CEJ Executive Director Maggie Mapalo Mwape said the exercise was funded by United Nations Democracy Fund (UNDEF), covering five districts namely Lusaka, Chirundu, Luangwa, Chongwe and Rufunsa. 

Ms Mwape said the transformative initiative aims to empower Civil Society Organizations in Zambia to play a pivotal role in advocating for climate action and environmental sustainability. 

Speaking in Luangwa after a Stakeholders mapping exercise to mark the project launch, Ms Mwape said CEJ will continue engaging with the local authorities and stakeholders.

“Now that the project has been launched in Luangwa, we shall proceed to launch the project in Rufunsa, Chongwe, Chirundu and Lusaka respectively. I am accompanied by Acting Head of Programmes Mr. Haggai Nyambe and Head of Logistics Mr Patrick Kashanga to ensure a smooth Programme,” she said. 

Ms Mwape said the success of Zambia’s National Adaptation Planning (NAP) processes and Nationally Determined Contribution (NDCs) implementation in the country hinges on the participation of several stakeholders including the civil society movement.

“It is for this reason that CEJ is building the capacity of CSOs in climate adaptation and implementation of nationally determined contributions,” she said. 

Meanwhile, Luangwa District Commissioner Luke Chikani said Government will support CEJ’s expedition to empower Civil Society Organizations capacity to champion climate change mitigation and adaptation issues effectively.

[/ihc-hide-content

Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer deaths are linked to one risk factor: smoking. While lung cancer screenings are a critical part of prevention and treatment for the disease and 15 million Americans qualify for yearly screenings, over half those eligible for screenings are still actively smoking. Without standard smoking cessation measures in place, the benefits of the screenings have not been fully realized.

A team of researchers at the University of Oxford, led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman’s likelihood of developing and then dying of breast cancer within a decade.

The elucidation of the role of a critical protein in cell biology is paving the way for alternative cancer treatments. By refuting recent challenges that threatened to invalidate their work, a team of KAUST researchers investigating the protein has cleared the way for the development of targeted drugs.